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We report that in the presence of signal 1 (NF-kB), the
NLRP3 inflammasome was activated by mitochon-
drial apoptotic signaling that licensed production of
interleukin-1b (IL-1b). NLRP3 secondary signal acti-
vators such as ATP induced mitochondrial dysfunc-
tion and apoptosis, resulting in release of oxidized
mitochondrial DNA (mtDNA) into the cytosol, where
it bound to and activated the NLRP3 inflammasome.
The antiapoptotic protein Bcl-2 inversely regulated
mitochondrial dysfunction and NLRP3 inflamma-
some activation. Mitochondrial DNA directly induced
NLRP3 inflammasome activation, because mac-
rophages lacking mtDNA had severely attenuated
IL-1b production, yet still underwent apoptosis.
Both binding of oxidizedmtDNA to theNLRP3 inflam-
masome and IL-1b secretion could be competitively
inhibited by the oxidized nucleoside 8-OH-dG.
Thus, our data reveal that oxidized mtDNA released
during programmed cell death causes activation of
the NLRP3 inflammasome. These results provide
amissing link between apoptosis and inflammasome
activation, via binding of cytosolic oxidizedmtDNA to
the NLRP3 inflammasome.
INTRODUCTION
Secretion of interleukin-1b (IL-1b), a potent pyrogen that elicits
a strong proinflammatory response (Dinarello, 2009), is tightly
controlled by a diverse class of cytosolic complexes known
as the inflammasome (Latz, 2010). The nucleotide bindingdomain and leucine-rich repeat (NLR) pyrin domain containing
3 (NLRP3) family member forms cytosolic oligomers with
apoptosis-associated speck-like protein (ASC) in dendritic cells
(Ghiringhelli et al., 2009) and macrophages (Franchi et al., 2009),
triggering autocatalytic activation of caspase-1 (Martinon et al.,
2009). Caspase-1, in turn, cleaves pro-IL-1b, producing mature
IL-1b. Under normal circumstances, NLRP3 undergoes bipartite
activation (Latz, 2010). The first signal (signal 1), often NF-kB
activation, induces pro-IL-1b and NLRP3 expression. The sec-
ond signal, any one of a variety of unrelated entities—particulate
matter, crystals, aggregated b-amyloid, extracellular ATP, or
microbial toxins—activates the NLRP3 inflammasome (Gross
et al., 2011). Exactly how these diverse cytosolic danger signals
trigger the same inflammasome remains unclear.
In the past, three models of NLRP3 activation were pro-
posed: reactive oxygen species (ROS) generation (Tschopp
and Schroder, 2010), lysosomal damage (Hornung and Latz,
2010), and cytosolic K+ efflux (Pe´trilli et al., 2007). Reports on
their relative contributions to NLRP3 activation have often been
contradictory and have not yielded an integrated, unified model.
Recently, two papers have reported an important role for mito-
chondria (mt) in NLRP3 inflammasome activation (Nakahira
et al., 2011; Zhou et al., 2011). Specifically, Zhou et al. (2011)
found that mt reactive oxygen species (ROS) is critical for
NLRP3 activation, whereas Nakahira et al. (2011) reported that
mtDNA plays an important role. However, the molecular mecha-
nism for NLRP3 activation has not yet been defined.
Mitochondria are exquisitely complex regulators of cytosolic
homeostasis, sensing and responding to changes in intracellular
K+ and ROS (Tschopp, 2011). Perturbation of intracellular K+,
ROS, or lysosomal stability can result in mt dysfunction and
apoptosis (Johansson et al., 2010; Tschopp, 2011). Therefore,
mt are well positioned to regulate NLRP3 activation. Our initial
investigation focusing on NLRP3 activation by Chlamydia pneu-
moniae (CP) infection led us to a serendipitous result thatImmunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc. 401
Figure 1. Mitochondrial Dysfunction Is Linked to NLRP3 Inflammasome Activation
(A–C) IL-1b and TNF-a concentrations (ELISA) in BMDM culture supernatants treated with (A) NLRP3-activating stimuli or (B) LPS (1 mg/ml) plus ATP (5 mM, final
2 hr culture) in the presence of increasing doses of chloramphenicol. Also shown is an LDH release assay of the sameBMDM. (C) The effect of Cyclosporin A (CsA)
on LPS+ATP-induced IL-1b in WT BMDM.
(D) Mitochondrial membrane potential (DJm) measurements during NLRP3 inflammasome activation. BMDMwere treated with UV-killed CP (UVCP, MOI = 10) or
live CP (MOI = 10), treated with ATP (5 mM) or staurosporine (STS, 5 mM) for 24 hr, and examined for TMRM incorporation.
(E) Changes in DJm were monitored over time by TMRM incorporation. BMDM were treated with live CP (MOI = 10), ATP (5 mM), STS (5 mM), nigericin (NIG,
10 mM), or alum (130 mg/ml).
(F and G) Changes in DJm resulting from ATP treatment as measured by TMRM microscopy. A representative image of mitochondrial TMRM fluorescence and
associated 3D intensity map are shown in (F). The kinetic profile shown in (G) depicts the mean value ± the SEM at each time point.
(H and I) Extracellular K+ affects (H) IL-1b secretion and (I) DJm as measured by TMRM incorporation. Four hours after LPS priming (1 mg/ml) or after CP infection
(MOI = 10), BMDM were transferred to culture media containing either 5 mM or 100 mM K+. Six hours after LPS priming, BMDM were then treated with ATP
(5 mM), STS (5 mM), or NIG (10 mM) and cultured for an additional 2 hr before culture supernatants were collected and IL-1b concentration was measured.
CP-infected BMDM were cultured for an additional 20 hr before supernatants were collected for IL-1b measurement.
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We found that mt damage specifically triggered apoptotic sig-
nals and induced NLRP3-dependent IL-1b secretion in primed
macrophages. This led to an innate immune defense program
where primed macrophages initiated a mt-dependent apo-
ptotic cascade in response to danger signals and cytosolic
stress, necessary and sufficient for caspase-1 activation by the
NLRP3 inflammasome in the presence of signal 1. This apoptotic
cascade activated the NLRP3 inflammasome through cytosolic
release of oxidized mtDNA, which bound to and activated the
NLRP3 inflammasome. Given that both mt dysfunction and
apoptosis are inextricably linked to ROS, intracellular K+, and
lysosomal degradation, the present work positions mt as the
central hub for integration of diverse signals sensed by NLRP3.
RESULTS
Mitochondrial Dysfunction Leads to IL-1b Secretion
During the course of investigating inflammasome activation after
mouse CP infection, we found that infection-induced IL-1b
secretion in macrophages required live bacteria and was depen-
dent on NLRP3, ASC, and caspase-1 (Figure 1A). On the other
hand, tumor necrosis factor alpha (TNF-a) secretion was inde-
pendent of NLRP3 inflammasome (Figure S1A available online).
While investigating the effects of chloramphenicol (CAM) on
CP-induced activation of NLRP3, we serendipitously discovered
that TNF-a production was enhanced in high-dose CAM-treated
bone marrow-derived macrophages (BMDM; data not shown).
Intrigued by this result, we treated lipopolysaccharide (LPS)-
primed BMDM with CAM before addition of ATP. This led to an
unexpected attenuation of IL-1b secretion but TNF-a produc-
tion increased reciprocally in proportion to IL-1b inhibition (Fig-
ure 1B). To rule out the possibility that CAM might be cytotoxic
in this scenario, we examined lactate dehydorgenase (LDH)
release in CAM-treated BMDM. To our surprise, CAM caused
a dose-dependent reduction in LDH release (Figure 1B), sug-
gesting that reduced IL-1b production is proportional to
BMDM survival.
Considering the high degree of homology between bacterial
and mt ribosomes and that CAM inhibits mt ribosomal protein
synthesis (Riesbeck et al., 1990), we hypothesized that the effect
of CAM on CP-induced IL-1b secretion might be due to attenu-
ation of a mt signal that activates the NLRP3 inflammasome.
To test this, we treated BMDM with LPS plus ATP in presence
of cyclosporin A (CsA), a mt inhibitor that blocks cytochrome c
release (Ghribi et al., 2001). CsA attenuated IL-1b secretion but
had no effect on TNF-a production (Figure 1C). These results
were similar to those found by others, collectively suggesting
a mitochondrial role in NLRP3 inflammasome activation (Naka-
hira et al., 2011; Zhou et al., 2011).
To further our investigation into mt and NLRP3 inflammasome
activation, we determined the effect of CP infection on inner mt
membrane potential (DJm), loss of which is a surrogate marker(J and K) Oxygen consumption rate (OCR) was measured in LPS-primed macrop
(J) Baseline OCR measurements 2 hr after ATP (5 mM), STS (5 mM), or NIG (10 m
(K) The change of OCR was monitored after 1 mM oligomycin, 1 mM FCCP, and 1
(L) Kinetics of OCR were monitored in macrophages in response to NLRP3 activ
Data shown are representative of two or more independent experiments (meansfor apoptosis (Ly et al., 2003). Live CP infection, ATP, and staur-
osporine (STS, a proapoptotic compound), but not ultraviolet
light-killed CP (UVCP) treatment, resulted in decreased DJm
(Figure 1D) as measured by tetramethyl rhodamine methyl ester
(TMRM) incorporation assay, further implicating mt in NLRP3
inflammasome activation. CP infection, ATP, STS, alum, and
nigericin (NIG, another proapoptotic compound) all led to irre-
versibly decreased DJm (Figure 1E), with attenuation as early
as 30 min posttreatment. Interestingly, incubation of BMDM
with NIG also reduced DJm (Figure 1E). ATP treatment of LPS-
primed BMDM resulted in a similar effect on DJm by TMRM
fluorescence microscopy (Figure 1F and Movie S1). Of note,
the kinetic differences observed between the incorporation
assay (Figure 1E) and TMRM (Figure 1F) may be due to greater
sensitivity of TMRM fluorescence microscopy. The addition of
ATP to macrophages resulted in a permanent decrease in
DJm, which was independent of both NLRP3 (Figure 1G) and
caspase-1 (Figure S1B). Because ATP and CP (but not UVCP)
caused reduced DJm and triggered caspase-1 activation by
NLRP3, we suggest that mt dysfunction is involved in NLRP3
inflammasome activation.
Low intracellular K+ has been linked to caspase-1 activation by
the NLRP3 inflammasome (Lamkanfi et al., 2009; Pe´trilli et al.,
2007). This conclusion is supported by studies showing that cells
exposed to a high concentrations (>90 mM) of K+ or treated with
K+ efflux inhibitors have attenuated NLRP3 activation in
response to various NLRP3 stimuli. To determine whether K+
efflux played a role in CP-induced NLRP3 activation, we infected
BMDM with CP and then exposed cells to 100 mM of extracel-
lular K+. Results showed that elevated extracellular K+ con-
centration almost completely blocked IL-1b secretion by CP-
infected BMDM (Figure 1H). Importantly, high extracellular K+
protected BMDM from DJm reduction (Figure 1I). To further
characterizemt dysfunction after NLRP3 inflammasome stimula-
tion, we analyzed oxygen consumption rate (OCR). Addition of
ATP, STS, or NIG to LPS-primed macrophages all attenuated
OCR and hence mt dysfunction (Figures 1J–1L). LPS priming
was not required for reduced OCR; incubation with ATP or NIG
alone reduced macrophage OCR (Figure S1C). Together, these
results further link mt with NLRP3 activation and also shed light
on the mechanism by which cytosolic K+ efflux triggers NLRP3.
Mitochondrial Apoptotic Signals Activate the NLRP3
Inflammasome
To further their own survival, intracellular pathogens subvert,
activate, or otherwise manipulate host cell death signaling path-
ways (Arnoult et al., 2009). Because mt play a crucial role as initi-
ator of cell death, and because our data thus far showed that mt
dysfunction occurred with inflammasome activation, we next
examined the putative role of mt cell death pathways in acti-
vating the NLRP3 inflammasome. We found that live CP, but
not UVCP, caused LDH release from infected BMDM, albeit
with reduced magnitude and slower kinetics versus ATP, STS,hages.
M) treatment.
mM Rotenone sequential additions.
ation.
± SD). *p < 0.05, **p < 0.01, ***p < 0.001.
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induced by LPS+ATP or NIG, we used Annexin V flow cytometry
and found that LPS+ATP or LPS+NIG induced apoptosis in
BMDM (Figure S2A). As an alternative approach, we scored
DAPI-stained cells for nuclear condensation. Nuclei of apoptotic
cells, unlike those of necrotic cells, exhibit highly condensed
chromatin that uniformly stained with DAPI. Consistent with
data from LDH release assays (Figure 2A), we observed in-
creased apoptosis in CP-infected macrophages but not in
UVCP-treated cells (Figure 2B). Thus, apoptosis induced by
CP is linked to NLRP3 inflammasome activation. Intriguingly,
the proapoptotic molecule STS not only led to loss of DJm (Fig-
ure 1D), LDH release (Figure 2A), and nuclear condensation (Fig-
ure 2B), but also to caspase-1 activation and subsequent IL-1b
maturation in LPS-primed BMDM (Figure 2C). Addition of STS
6 hr after UVCP or LPS treatment induced IL-1b secretion that
was enhanced after CP infection (Figure 2D) and was predomi-
nately dependent on NLRP3/ASC/caspase-1 (Figure 2E). STS
treatment did not affect TNF-a production (Figure 2D). Collec-
tively, these results indicate that an apoptotic stimulus activates
caspase-1 and induces IL-1b secretion via the NLRP3 inflamma-
some in primed macrophages.
To further substantiate that apoptotic processes act as the
second signal for NLRP3 activation, we examined the timing of
NLRP3 activation with respect to LPS, UVCP, and CP. If STS
or ATP was added before or simultaneously with UVCP or LPS,
IL-1b secretion was undetectable (Figure 2F). A similar pattern
of results was observed when STS or ATP was added con-
comitantly with CP infection (Figure 2F). Yet, if STS or ATP was
added 6 hr after LPS or UVCP priming, IL-1b secretion was in-
creased (Figure 2F). These data further substantiate that ATP
and STS rapidly induce apoptosis (as initially shown in Figures
2A and 2B), which would prevent cleavage and secretion of
IL-1b because signal 1 has not had enough time to prime the
cells for induction of pro-IL-1b. To determine whether apoptotic
cells themselves were releasing IL-1b, we used immunohisto-
chemistry. Indeed, secretion of IL-1b (indicated by a disappear-
ance of cytosolic IL-1b staining) in response to CP or LPS+ATP
was caspase-1 dependent and was more frequent in apoptotic
cells (those with condensed nuclei, Figure 2G). This argued
against the possibility that ATP released from dying cells
activated the NLRP3 inflammasome of neighboring cells in a
paracrine manner. Further ruling out this bystander effect, CP-
infected or alum-treated macrophages given apyrase, an
enzyme that rapidly hydrolyzes extracellular ATP, exhibited no
difference in IL-1b secretion compared to untreated cells (data
not shown). These results demonstrate that activation of the
NLRP3 inflammasome by an apoptotic stimulus must occur
after, but not before or concomitant with, innate immune cell
priming.
Recent studies have described a caspase-1-dependent form
of programmed cell death called pyroptosis (Fink and Cookson,
2005). To rule out pyroptosis as the source of mt dysfunction and
cell death, we assessed DJm reduction in response to CP, ATP,
STS, NIG, and alum in caspase-1-deficient (Casp1–/–) BMDM. In
all cases studied, mitochondrial depolarization was independent
of caspase-1 (Figure S2B), suggesting that pyroptosis does not
play a role. We also assessed LDH release after CP infection in
BMDM and found that caspase-1 also did not play a role (Fig-404 Immunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc.ure S2C). Additionally, LPS-primed BMDM treated with necrotic
stimuli did not secrete IL-1b (Figure S2D).
We also investigated the ability of another known inducer of
apoptosis, A23817 (a Ca2+ ionophore), to activate the inflam-
masome. Importantly, A23817 did induce IL-1b under LPS-acti-
vating conditions (Figure S2E). This is in agreement with our
finding that A23817 resulted in loss of mitochondrial membrane
potential and substantial LDH release (Figure S2E). Additionally,
LPS+Fas ligand (FasL) treatment did not activate the inflamma-
some as determined by IL-1b secretion (Figure S2E). However,
FasL did not induce copious LDH release, nor reduce the mito-
chondrial membrane potential, indicating that BMDM might be
insensitive to FasL.
Bcl-2 Expression Regulates NLRP3 Inflammasome
Activation and IL-1b Secretion
To verify that macrophage apoptosis was required for NLRP3
activation, we stably transfected an immortalized macrophage
cell line, MCL (Hornung et al., 2008), with a vector encoding
the antiapoptotic protein Bcl-2 (Figure 3A), and assessed IL-1b
secretion in response to NLRP3 triggers. The Bcl-2-overex-
pressing line secreted significantly less IL-1b compared to cells
with an empty vector control (or versus cells expressing an unre-
lated gene, yellow fluorescent protein, YFP; Figure S2F) in
response to CP, LPS+ATP, LPS+STS, or LPS+NIG (Figure 3B).
TNF-a secretion was unaffected in all cases (Figure 3B). Pro-
tein immunoblot analyses revealed similar results with re-
duced amounts of both intracellular caspase-1 p10 and mature
(secreted) IL-1b (Figure 3C). Importantly, the Bcl-2-overexpress-
ing MCL line was resistant both to changes in DJm (Figure 3D)
and to apoptosis in response to numerous stimuli (Figures 3E
and S2A). We also derived BMDM from Bcl-2 transgenic (Bcl-
2-tg) mice and performed similar studies. Indeed, these macro-
phages secreted significantly less IL-1b in response to a host of
NLRP3 stimuli (Figure 3F), whereas TNF-a secretion was unal-
tered. Thus, inhibition of apoptosis at the level of mt is sufficient
to cause reduced IL-1b maturation and secretion triggered by
NLRP3-activating stimuli. Finally, we stably transfected MCL
cells with a vector encoding shRNA for Bcl-2 that efficiently
reduced Bcl-2 protein abundance (Figure 3G). Attenuated
Bcl-2 protein should result in increased apoptosis and, as ex-
pected, LDH release was elevated (Figure 3H). With LPS+ATP
to stimulate the NLRP3 inflammasome, these cells secreted
more IL-1b but not TNF-a (Figure 3I). Based on these re-
sults, apoptotic processes blocked by Bcl-2 are necessary for
NLRP3 activation.
Salmonella typhimurium Infection-Induced Apoptosis
Causes IL-1b Secretion
S. typhimurium (St) is recognized by both the NLRP3 and NLRC4
inflammasome pathways (Broz et al., 2010). Indeed, NLRP3
plays an important role in IL-1b secretion induced by St recogni-
tion (Figure 4A). St is also known to induce type III secretion
system (T3SS)-dependent apoptosis in macrophages (Hersh
et al., 1999; Kage et al., 2008), and we investigated whether St
activation of the NLRP3 inflammasome was licensed by apo-
ptosis. St infection of BMDM for 8 hr resulted in marked LDH
release (90% of control) (Figure 4B). However, T3SS-1-defective
strains of St (invA, hilA, orgA, and prgH) did not induce LDH
Figure 2. Apoptotic Stimuli Activate the NLRP3 Inflammasome in Macrophages
(A and B) BMDMwere treated with UVCP (MOI = 10), live CP (MOI = 10), ATP (5 mM), STS (5 mM), or alum (130 mg/ml) and (A) LDH release was determined at the
indicated time points or (B) cells were fixed and stained with DAPI, and condensed nuclei were enumerated.
(C) Immunoblotting was used to analyze mouse caspase-1, pro-IL-1b, and IL-1b in culture supernatants and lysates of BMDM treated with (left to right): UVCP
(MOI of 10, 8 hr), live CP (MOI of 10, 8 hr), LPS (1 mg/ml, 8 hr), ATP alone (5 mM), LPS+ATP, STS alone (5 mM), or LPS+STS (5 mM, final 2 hr of culture).
(D and E) IL-1b or TNF-a secretion by (D) wild-type (WT) or Casp1–/– or (E) WT, Asc–/–, or Nlrp3–/– BMDM was measured by ELISA after UVCP, live CP (MOI = 10
and 8 hr), or LPS (1 mg/ml, for 8 hr) treatment in presence of STS (2.5 mM or 5 mM) for the final 2 hr of culture.
(F) IL-1b secretion was quantified by ELISA in BMDM primed with UVCP, live CP, or LPS and then treated with ATP or STS at 0 hr or 6 hr after priming.
(G) BMDM were treated with live CP, LPS, LPS+ATP, or ATP alone as indicated. Cells were analyzed by immunofluorescence for IL-1b and DAPI.
Scale bars represent 10 mm. Data shown are representative of three or more independent experiments (means ± SD).
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Figure 3. Bcl-2 Inversely Regulates Mitochondrial Dysfunction and NLRP3 Inflammasome Activation
(A) Bcl-2-neor or empty vector (EV, neor) was stably expressed in MCL macrophages, and Bcl2 expression was determined by immunoblot.
(B and C) Bcl-2 overexpressing macrophages were treated with live CP (MOI = 10, 24 hr), LPS (1 mg/ml, 5 hr), ATP (5 mM, final 2 hr of culture), LPS+ATP, STS
(5 mM, final 2 hr of culture), LPS+STS, NIG (10 mM, final 2 hr), or LPS+NIG and then (B) IL-1b or TNF-a secretionwasmeasured by ELISA or (C) immunoblottingwas
used to analyze mouse capsase-1, pro-IL-1b, or IL-1b in culture supernatants or cell lysates.
(D and E) DJm (D) and apoptotic cells (E) were measured after NLRP3 inflammasome stimulation at 8 hr for CP, or at 4 hr for ATP, STS, and NIG.
(F) BMDM from Bcl-2 transgenic mice were treated with live CP, LPS, LPS+ATP, LPS+STS, LPS+NIG, or LPS+alum (130 mg/ml, final 8 hr). IL-1b and TNF-a
secretion were then measured by ELISA.
(G) Validation of shRNA targeting Bcl-2 in stably expressing MCL macrophages by immunoblot.
(H and I) shBcl-2 macrophages were primed with LPS and treated with ATP (5 mM for 4 hr), and (H) LDH release, (I) IL-1b, or TNF-a were then measured in
supernatants. Data shown are representative of three or more independent experiments (means ± SD).
*p < 0.05, **p < 0.01, ***p < 0.001.
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nonsignaling strain (msbB) induced LDH release (Figure 4B).
Finally, the invasin mutant (sspB) did not induce LDH release.
Accordingly, LDH release inversely correlated with DJm in
LDH-inducing strains, whereas DJm remained unaltered in non-
LDH-releasing mutants (Figure 4C). As a control, poly(dA:dT),
which utilizes absent in melanoma 2 (AIM2) but not NLRP3, did406 Immunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc.not induce changes in DJm. Importantly, IL-1b secretion was
induced only by St strains that caused LDH release and DJm
reduction (Figure 4D) and was not secreted after infection
with strains that did not induce apoptosis. To further test whether
IL-1b secretion resulting fromSt infection-induced apoptosis, we
infected the Bcl-2 stably transfected MCL cell line with wild-type
St. Bcl-2 overexpression significantly reduced IL-1b secretion
Figure 4. Salmonella Type III Secretion Protein and Invasion Factor SipB Induces Mitochondrial Depolarization and Caspase-1-Dependent
IL-1b Secretion
(A) 3 hr LPS-primed Nlrp3–/– BMDM were exposed to wild-type (St wt) or nonflagellated mutant St (St DfljB/fliC) (MOI = 5) and IL-1b was quantified in culture
supernatants by ELISA.
(B and C) 3 hr LPS-primed BMDM were exposed to various strains of St (MOI = 5) and (B) cell viability was determined by LDH release assay or (C) DJm was
measured by TMRM incorporation.
(D and E) IL-1b or TNF-a were quantified in culture supernatants by ELISA in (D) WT and Casp1–/– macrophages or in (E) WT and Bcl-2-overexpressing
macrophages that were exposed to St (MOI = 5).
Data shown are representative of three or more independent experiments (means ± SD).*p < 0.05, **p < 0.01, ***p < 0.001.
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pected, however, TNF-a secretion was similar between groups
(Figure 4E). It should be noted that Bcl-2 overexpression did
not impact LPS+poly(dA:dT) treatment outcomes (Figure 4E),
presumably because poly(dA:dT) utilizes AIM2 and not NLRP3.
Together, these data further substantiate the requirement of
apoptosis for NLRP3 inflammasome activation.
Mitochondrial DNA Is Required for NLRP3
Inflammasome-Mediated IL-1b Secretion
Recently, Nakahira et al. (2011) suggested that mtDNA was
involved in NLRP3 activation, but the exact mechanism for this
was not elucidated. Corroborating results of Nakahira et al.
(2011), we found that r0 cells (lacking mtDNA) were unable
to secrete IL-1b in response to NLRP3-inducing stimuli, whereas
TNF-a secretion remained unaltered (Figures S3A–S3D).
Patrushev et al. (2006) reported that mtDNA is released into
the cytosol during intrinsic apoptosis. Thus, we hypothesized
that mtDNA released into the cytosol during apoptosis might
trigger NLRP3 inflammasome activation. To begin testing this,
we examined cytosolic DNA content after stimulation with
LPS+ATP or LPS+NIG. Shortly (15–30 min) after treatment with
ATP or NIG, the mitochondrial genes Cox1 and Nd3were readily
detected in the cytosol by PCR, but genomic DNA encoding
Gapdh was undetectable in this cellular compartment (Fig-ure S3E). We further hypothesized that cytosolic mtDNA might
directly bind NLRP3. Therefore, we cotransfected 293 cells
with a NLRP3-Flag construct and purified mtDNA previously
labeled with bromodeoxyuridine (BrdU). NLRP3 was subse-
quently immunoprecipitated (IP) with Flag M2 antibody, and
IP products were BrdU dot-blotted. BrdU signal was clearly
detected, indicating that mtDNA directly or indirectly associated
with NLRP3 (Figure 5A). To control for nonspecific binding, we
transfected BrdU-labeled mtDNA into 293 cells previously trans-
fected with a NOD2 expression vector. NOD2 did not co-IP
with mtDNA, whereas NLRP3 did in the same experiment (Fig-
ure S3F), suggesting specificity among NLRs. Similar to Naka-
hira et al. (2011), IL-1b secretion induced by BMDM-transfected
mtDNA was predominantly AIM2 dependent (Figure S3G).
Therefore, we also tested whether overexpressed AIM2 could
bind transfected mtDNA. As expected, AIM2 interacted with
the transfected DNA (Figure S3F). We probed for colocalization
of BrdU-labeled mtDNA with NLRP3 by microscopy and found
colocalization of BrdU-labeled mtDNA with NLRP3 (Figures 5B
and 5C).
To ensure that mtDNA-NLRP3 interaction was not owed to
overexpression artifact, we investigated whether endogenous
mtDNA interacted with native NLRP3 during inflammasome
activation. BMDM were grown in the presence of BrdU and
then treated with LPS+ATP or LPS+NIG in presence of theImmunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc. 407
Figure 5. Mitochondrial DNA Colocalizes with NLRP3
(A) Flag-NLRP3 and empty vector (EV) stably expressing 293 cells were
exposed to BrdU-labeled mitochondrial DNA (mtDNA) in presence of lip-
ofectamine. Cell lysates were collected 3 hr later and immunoprecipitated.
mtDNA was detected by BrdU dot-blot, and NLRP3 Ab was used for immu-
noblotting as a loading control.
(B and C) YFP-tagged NLRP3 stably expressing 293 cells were exposed to
BrdU-labeled mitochondrial DNA plus lipofectamine. 3 hr after exposure, cells
were fixed, permeabilized, treated with DNase I (10 U/ml, 30 min), and stained
with BrdU Ab. (B) Colocalization of YFP-NLRP3 and mtDNA was analyzed by
structured illumination microscopy, and (C) shows an orthogonal view from
a z-series.
Scale bars represent 10 mm.
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After NLRP3 IP, BrdU dot-blot was conducted. BrdU-incorpo-
rated DNA was bound to NLRP3 in cells treated with LPS+ATP
or LPS+NIG, whereas LPS treatment alone did not produce
NLRP3-BrdU binding (Figures 6A and S4A), indicating that sec-
ondary stimulation was necessary for this interaction. To exclude
nonspecific binding of BrdU-incorporated DNA with NLRP3,
NLRP1 or AIM2 were subjected to IP and probed for BrdU.408 Immunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc.Importantly, BrdU-labeled DNA did not co-IP with NLRP1 or
AIM2 (Figure 6B). That endogenous AIM2 did not associate
with DNA under NLRP3-activating conditions, but interacted
with transfected DNA (Figure S3F), suggested that cellular local-
ization of and access to DNA are critical factors in determining
whether NLRP3 or AIM2 is activated. We next investigated the
origin of the DNA by performing PCR on the BrdU-incorporated,
NLRP3-bound DNA. By using primers specific for nuclear versus
mtDNA, we detected only mtDNA (Figure 6C) after NLRP3 IP.
Thus, mtDNA released into the cytosol-bound NLRP3.
Cytochrome c (Cyt-c), released from the mitochondria during
apoptosis, is also liberated after ATP stimulation (Nakahira
et al., 2011). We therefore investigated whether the Cyt-c
released from the mitochondria during NLRP3 inflammasome
activation (under LPS+ATP conditions) might also co-IP with
NLRP3. However, Cyt-c was undetectable in our NLRP3 pull-
downs (Figure S4B), suggesting that Cyt-c does not play a direct
role in NLRP3 activation.
Previous studies have indicated that mtROS might play an
important role in NLRP3 activation (Nakahira et al., 2011; Zhou
et al., 2011). Indeed, upon stimulation with LPS+ATP, mtROS
was substantially increased (Figure 6D and Movie S2). Impor-
tantly, generation of mtROS downstream of ATP stimulation
was caspase-1 independent (Figure 6D). Because ATP induced
mtROS and it is well-known that mtROS generation can result in
oxidized mtDNA, we probed NLRP3 immunoprecipitates for the
oxidized DNA indicator 8-hydroxy-guanosine (8-OH-dG). We
found that under LPS+ATP conditions, 8-OH-dG was detected
in the pull-downs (Figures 6A and S4C). The oxidized nucleoside
8-OH-dG was also found under LPS+NIG conditions, although
at a reduced amount compared with LPS+ATP (Figures 6A
and S4C).
To further assess the role of oxidized mtDNA during NLRP3
activation, we investigated 8-OH-dG induction under NLRP3-
activating conditions. When BMDM were exposed to either
ATP or NIG, 8-OH-dG concentration increased (Figure 6E). Addi-
tion of LPS to either ATP or NIG resulted in further increased
8-OH-dG abundance (Figure 6E). This finding dovetails with
a recent report showing that TLR signaling enhances mtROS
production (West et al., 2011). These data were corroborated
by an in-depth analysis of mtDNA by liquid chromatography-
tandem mass spectrometry (LC-MS-MS) that revealed a 3-fold
increase in 8-OH-dG abundance in mtDNA from BMDM treated
with LPS+ATP versus LPS alone (Figure 6F). We also investi-
gated whether transfected oxidized DNA may colocalize with
NLRP3 in 293 cells and found that this did indeed occur (Figures
S4D and S4E). Finally, NLRP3 was pulled down with oxidized
DNA in caspase-1-deficient macrophages, again indicating
that all the events take place prior to caspase-1 activation (Fig-
ures 6G and S4F) and ruling out downstream events derived
from caspase-1 activity.
We next assessed whether oxidized DNA versus normal DNA
could enhance IL-1b production. Oxidized DNA was generated
by PCR against the mtCOX1 template in the presence of
8-OH-dGTP, and PCR products were transfected into BMDM.
IL-1b production was significantly enhanced with oxidized
versus normal DNA (Figure 6H). Importantly, oxidized DNA did
not impact TNF-a production. However, the same experiment
performed in Nlrp3–/– BMDM resulted in significantly decreased
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containing 8-OH-dGTP could still induce IL-1b secretion in
Aim2–/– BMDM (Figure 6J), despite the fact that these cells
were refractive to mtDNA transfection-induced IL-1b release
(Figure S3G). Taken together, these data indicate that oxidized
DNA can induce inflammasome activation via preferential activa-
tion of NLRP3 and not AIM2.
We next investigated whether 8-OH-dG might competitively
inhibit NLRP3 inflammasome activation by preventing the
binding of oxidized mtDNA to NLRP3. Under NLRP3-activating
conditions, we added increasing amounts of either dG or 8-OH-
dG into themedia concurrent with LPS treatment. Although addi-
tion of dG had no effect on IL-1b production, 8-OH-dG was able
to significantly reduce IL-1b secretion (Figure 7A) but did not
affect TNF-a secretion (Figure S5A). As expected, 8-OH-dG did
not inhibit AIM2 stimulation (Figure 7B). To ascertain the mecha-
nism by which 8-OH-dG inhibited IL-1b secretion, we repeated
the NLRP3 and BrdU-incorporated mtDNA IP experiment under
LPS+ATP conditions, but in the presence of either dG or 8-OH-
dG. Importantly, 8-OH-dG prevented BrdU-incorporatedmtDNA
from coprecipitating with NLRP3 (Figures 7C and S5B). Finally,
we probed 8-OH-dG in NLRP3 pull-downs and found that under
8-OH-dG conditions, instead of BrdU mtDNA, only 8-OH-dG
came down with NLRP3 (Figures 7C and S5C). Thus, 8-OH-dG
competitively inhibitedNLRP3-mtDNA interaction andprevented
IL-1b secretion. Together, these data indicate that oxidized
mtDNA, generated and released into the cytosol during apo-
ptosis, is the actual binding motif for NLRP3 and activates the
NLRP3 inflammasome.
DISCUSSION
The NLRP3 inflammasome is a critical nexus mediating IL-1b
and IL-18 responses to pathogens and innate immune stimuli.
Because inflammasome stimuli are diverse and often unrelated,
discerning themechanism of NLRP3 activation has been elusive.
Recent evidence has begun to indicate mt as key players in
NLRP3 inflammasome signaling (Nakahira et al., 2011; Zhou
et al., 2011). During our analysis of CP infection, we serendipi-
tously uncovered evidence that mt might play an important
role in activating the NLRP3 inflammasome. In this report, we
have provided a mechanistic explanation for NLRP3 activation,
where mt sense cellular danger that results in apoptosis, during
which oxidized mtDNA is released into the cytosol and binds to
NLRP3. This cascade of events resulted in activation of the
NLRP3 inflammasome and caspase-1 maturation.
The identification of mt as key players in NLRP3 inflamma-
some induction places apoptosis at the epicenter of this impor-
tant process. As both sensors and robust sources of ROS, mt
rapidly respond by releasing Cyt-c and inducing apoptosis (Ott
et al., 2007). Moreover, cathepsins and ROS released during
lysosomal rupture can also profoundly impact mt membrane
integrity, causing membrane permeabilization and subsequent
initiation of apoptosis (Boya et al., 2003; Ferri and Kroemer,
2001). The mt K+ cycle, inexorably linked to intracellular K+ con-
centration, is obligatorily central to maintaining mt volume, con-
trolling metabolic ROS (Garlid and Paucek, 2003) and inducing
apoptosis (Park and Kim, 2002). We have shown that, while
capable of blocking IL-1b secretion in response to NLRP3 trig-gers, inhibiting K+ efflux by high concentrations of extracellular
K+ exerted profound effects on mt and mitigated loss of DJm
in response to NLRP3 activators. Indeed, it has often been
overlooked that modulating cell surface K+ channels inevitably
results in altered activation of mitochondrial K+ channels. But
how do mt activate the NLRP3 inflammasome?
Our data demonstrated that NLRP3 triggers, such as alum,
ATP, NIG, and live CP, cause mt dysfunction and cell death in
macrophages. We have also shown that STS, a proapoptotic
compound, was sufficient to act as a second signal for NLRP3
activation. Moreover, LPS-primed macrophages treated with
NLRP3 activators secreted less IL-1b but similar amounts
of TNF-a in the presence of CsA. Apoptosis was critical for
NLRP3 inflammasome induction, because overexpression of
antiapoptotic Bcl2 attenuated IL-1b secretion by LPS-primed
macrophages and Bcl2 silencing resulted in the converse. St
type III secretion mutants unable to induce apoptosis did not
promote IL-1b secretion, and Bcl2 overexpression inhibited
wild-type St infection-induced IL-1b secretion. Given that the
physiological triggers of NLRP3 are inextricably linked to mt
and apoptosis and that a causal relationship exists between pro-
apoptotic signals andNLRP3, it seems that apoptosis is an indis-
pensable step in NLRP3 inflammasome activation. Although
apoptosis is often portrayed as ‘‘silent’’ cell death, our data sug-
gest that in the presence of proinflammatory signal 1, the apo-
ptotic machinery activates the NLRP3 inflammasome. Thus,
apoptosis can activate the NLRP3 inflammasome, but remains
a silent death unless in the context of signal 1.
Although the role of Bcl-2 in apoptosis is well appreciated, it
has been suggested that Bcl-2 may more directly activate the
inflammasome. For example, Bcl-2 can directly bind NLRP1
and inhibit NLRP1 activation (Bruey et al., 2007; Faustin et al.,
2009). These data raise the possibility of alternative pathways
by which Bcl-2 might inhibit NLRP3 activation. However, these
investigators did find that Bcl-2 does not bind NLRP3. Addi-
tionally, whether inhibition of NLRP1 activation occurs in vivo is
unclear because they stimulated Bcl2/ and Bcl2-overexpress-
ing macrophages with MDP+ATP, and ATP is a well-known
NLRP3 activator (Mariathasan et al., 2006b; Sutterwala et al.,
2006). Given these data, plus the known effect of Bcl-2 on the
apoptotic machinery, it is unlikely that Bcl-2 is directly involved
in NLRP3 inflammasome activation.
At this point, it is not knownwhether both intrinsic and extrinsic
apoptosis can induce the NLRP3 inflammasome together with
signal 1, because all of the apoptosis inducers we tested were
intrinsic. Therefore, we also investigated whether Fas ligand
(FasL) could induce IL-1b secretion in LPS-primed BMDM, but
we did not detect IL-1b release or any reduction in mt membrane
potential. However, exposure of BMDM to FasL did not induce
a robust apoptotic response, suggesting that BMDMare partially
insensitive to the apoptotic effects of FasL. We therefore cannot
exclude a potential role for extrinsic apoptosis in NLRP3 inflam-
masome activation.
It is not clear how oligomeric NLRP3 inflammasome com-
plexes sense such a wide range of cytosolic danger signals,
including ATP, K+ efflux, alum, uric acid crystals, b-amyloid,
and various microbial infections (Jin and Flavell, 2010; Schroder
and Tschopp, 2010). As such, in a mechanism distinct from
pattern recognition receptors, NLRP3 does not seem to senseImmunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc. 409
Figure 6. Oxidized Mitochondrial DNA Binds to NLRP3 and Activates the Inflammasome
(A) BMDM were preloaded with BrdU (10 mM), and cells were treated with LPS (1 mg/ml, 3 hr), followed by 3-MA (2.5 mM, 1 hr), ATP (5 mM, 1 hr), or NIG (10 mM,
1 hr). Cell lysates were collected and immunoprecipitated with NLRP3 Ab, then detected by dot-blots probed with BrdU or 8-OH-dG Abs. As a loading control,
NLRP3 immunoblot was performed.
(B) BrdU-preloaded BMDM were treated with LPS+ATP, and cell lysates were immunoprecipitated with Ab against NLRP1, NRLP3, or AIM2. Immune dot-blots
with BrdU Ab and respective control immunoblots are shown.
(C) Mitochondrial COX1 DNA associates with NLRP3 immunoprecipitates. COX1 DNA was amplified from the NLRP3 immunoprecipitates by PCR.
(D) BMDMwere stimulated with or without LPS for 3 hr, then loaded with 2.5 mMMitoSOX for 20min. Mitochondrial ROSwasmeasured every 30 s thereafter. ATP
was added 240 s after monitoring was initiated. Relative mitochondrial ROS increase at 30 min after ATP was shown.
(E and F) Mitochondrial DNA was extracted from BMDM after NLRP3 inflammasome stimulation, and amounts of 8-OH-dG were quantified by (E) ELISA and (F)
LC-MS-MS (means ± SD).
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Figure 7. 8-OH-dG Inhibits mtDNA from Binding to and Activating the NLRP3 Inflammasome
(A and B) BMDM were stimulated with LPS (1 mg/ml) in the presence of deoxyguanosine (dG) and 8-OH-dG, then treated with (A) ATP ± NIG or (B) poly(dA:dT)
(2 mg/ml), and IL-1b release was quantified by ELISA (means ± SD). *p < 0.05.
(C) BMDM were primed with LPS (1 mg/ml, 3 hr) in the presence of dG or 8-OH-dG (200 mM), pretreated with 3-MA (2.5 mM for 1 hr), and then treated with ATP
(5 mM, 1 hr). IP with NLRP3 Ab was performed, and BrdU or 8-OH-dG dot-blotting was carried out by immunoblotting. NLRP3 is shown as a loading control.
Data shown are representative of three or more independent experiments.
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(LRR) domain. Instead, it is believed that three broad physio-
logical changes—ROS generation, K+ efflux, and lysosomal
leakage—activate the NLRP3 inflammasome (Stutz et al.,
2009). Yet, it did not seem possible to reconcile these three
NLRP3 activation models with one another, and so the mecha-
nism by which the NLRP3 inflammasome was activated by
diverse signals remained perplexing. Our model of oxidized
mtDNA binding to NLRP3 as the activation step neatly assem-
bles and unifies previous models of NLRP3 activation. Although
we found that oxidized mtDNA associated with the NLRP3
inflammasome after stimulation, our data utilizing 293 cells
transfected with mtDNA suggest that mtDNA can directly bind
NLRP3. However, these results do not rule out the association
of the mtDNA with other members of the NLRP3 inflammasome
complex.
Two recent investigations have linked autophagy and inflam-
masome activation with mt activity. The first report found that
blocking autophagy results in accumulation of mt-driven ROS
formation, which in turn activates the NLRP3 inflammasome
(Zhou et al., 2011). Our results presented here generally agree
with the basic findings of the Zhou et al. (2011) report. Specifi-
cally, those authors concluded that apoptosis was not involved
in their system based on lack of LDH release after various stimuli.
Moreover, they were unable to detect LDH release after expo-
sure to NIG; a proton ionophore that causes cytosolic acidifica-
tion and has been shown to decrease intracellular pH and induce
apoptosis in other models (Yamagata and Tannock, 1996; Yang
et al., 2008). Indeed, we found that NIG induced nuclear conden-
sation, and another group reported LDH release after NIG expo-
sure (Shimada et al., 2010). Interestingly, although Zhou et al.
(2011) did not detect LDH release after monosodium urate treat-
ment, this compound may have off-target effects because it has
been shown to inhibit neutrophil apoptosis at low concentrations
but causes LDH release at higher levels (Akahoshi et al., 1997).(G) 8-OH-dG immune dot-blots were performed in WT, Casp1–/–, and Nlrp3–/– BM
2 hr, followed by stimulation with ATP for 30 min. Cell lysates were collected an
Casp1–/–, and Nlrp3–/– BMDM.
(H and I) LPS-primed (H)WT or (I)Nlrp3–/–BMDMwere treated with exogenous 8-O
TNFa amounts were quantified in supernatants by ELISA (means ± SD).
(J) LPS-primed Aim2–/– BMDM were treated with exogenous oxDNA (2 mg/ml), an
ELISA (means ± SD).Nonetheless, when considering the preponderance of data we
present in this study linking apoptosis and NLRP3 activation, it
seems that initiation of apoptotic events is required for proper
NLRP3 activation.
Both Zhou et al. (2011) and Nakahira et al. (2011) found that
mt-derived ROS are required for NLRP3 activation. However,
Nakahira et al. (2011) also found that mtDNA release is critical
for NLRP3 activation, and this is dependent on ROS generation.
We also observed that mtDNA was released into the cytosol and
that its presence was absolutely required for NLRP3 activation.
However, Nakahira et al. (2011) concluded that NLRP3 itself is
required for mtDNA release, because they did not detect mtDNA
in the cytosol of NLRP3-deficient macrophages. Importantly,
our results suggest that transfected mtDNA can bind to NLRP3
overexpressed in 293 cells and that DNA released frommt during
apoptosis binds to the NLRP3 inflammasome. Therefore, a likely
explanation for the lack of cytosolic mtDNA in NLRP3-deficient
macrophages in the study by Nakahira et al. (2011) is that
NLRP3 itself stabilizes mtDNA in the cytosol by binding to it.
The direct binding of mtDNA to NLRP3 could therefore be the
triggering mechanism for NLRP3 activation.
During apoptosis, ROS and oxidized mtDNA are generated
(Esteve et al., 1999). Our data indicate that it is this oxidized
form of mtDNA that binds to and activates the NLRP3 inflamma-
some and that this interaction can be competitively inhibited by
oxidized dG. One possibility for the inhibition by 8-OH-dG could
be through the prevention of ATP binding on NLRP3 (Duncan
et al., 2007) instead of directly competing with oxidized mtDNA
binding. Perhaps ATP binding and hydrolysis is required for
proper mtDNA binding. However, although our data do not rule
out this possibility, the end result is a lack of mtDNA binding,
which is required for NLRP3 activation. Therefore, our data are
in agreement with previous studies regarding the importance
of mtROS and now provide the putative mechanism for NLRP3
inflammasome activation. Additionally, although it appears thatDM after LPS+ATP treatment. LPS-primed BMDM were treated with 3-MA for
d NLRP3 immunoprecipitation and 8-OH-dG dot-blot were performed in WT,
H-dGTP incorporated DNA (oxDNA, 2 mg/ml) or control DNA for 8 hr. IL-1b and
d IL-1b and TNF-a concentrations were determined in culture supernatants by
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AIM2 is preferentially activated by normal DNA, and NLRP3, by
oxidized DNA.
Our data clearly show that induction of apoptosis is required
for NLRP3 inflammasome activation; however, we do not know
at what point in the signaling cascade the two events diverge.
According to ourmodel, both the apoptosome and theNLRP3 in-
flammasome share common upstream activating factors derived
from mt. However, it is a byproduct of apoptosis, oxidized
mtDNA released into the cytosol, which seems to be the acti-
vating factor for the NLRP3 inflammasome. The divergence of
the two pathways after initiation of apoptosis is evidenced by
the fact that mice deficient in Apaf-1, caspase-9, or caspase-3
exhibit infertility, abnormal brain development, and lethality
(Honarpour et al., 2000; Kuida et al., 1996, 1998) whereas no
such phenotypes have been found for caspase-1-, NLRP3-, or
ASC-deficient mice. Thus, although the two pathways share a
common origin, their downstream effects are different.
In toto, we have shown that mt dysfunction leading to apo-
ptosis occurs with, and is necessary and sufficient for, NLRP3
activation in the presence of signal 1. The generation of oxidized
mtDNA in this process of apoptosis and NLRP3 inflammasome
activation presents some intriguing possibilities regarding dis-
eases such as diabetes. NLRP3 has been shown to play an
important role in type II diabetes (Masters et al., 2010) and inter-
estingly, high concentrations of 8-OH-dG (representative of
damaged DNA) have been associated with both type I and
type II diabetes (Hinokio et al., 1999; Simone et al., 2008). One
could speculate that the increased amounts of oxidized DNA
generated in diabetes could be derived from the processes
that induce NLRP3 activation.
A key implication of the present study is that inhibition of
apoptosis by intracellular microbes serves a dual role: attenua-
tion of IL-1b secretion and maintenance of a viable host cell for
intracellular growth. Moreover, our results suggest that evolution
has developed an innate immune strategy that relies on mt to
determine the right time to sacrifice a jeopardized host cell for
the sake of initiating a strong inflammatory cascade via IL-1b.
Therefore, apoptosis is not always silent; rather, it can be a
powerful voice to instruct nearby cells of imminent danger in
the presence of NF-kB-activating signal 1.
EXPERIMENTAL PROCEDURES
Mice
Casp1–/– mice (Kuida et al., 1995) were kindly provided by R.A. Flavell (Yale
University, New Haven, CT). Nlrp3–/–, Asc–/– (Mariathasan et al., 2006a), and
Aim2–/– mice were supplied by K.A. Fitzgerald (University of Massachusetts
Medical School, Worcester, MA). C57BL/6 mice were obtained from the Jack-
son Laboratories (Bar Harbor, ME) and all animal experiments were conducted
according to Cedars-Sinai Medical Center Institutional Animal Care and Use
Committee guidelines. All mice were used at 8–12 weeks of age and were
matched for gender.
Measurement of Mitochondrial Membrane Potential and ROS
Cells were stained with the cationic dye TMRM (AnaSpec, Fremont, CA) or
mitochondrial superoxide indicator MitoSOX (Invitrogen) as described in the
manufacturer’s protocol. Cells were loaded with 200 nM of TMRM for 30 min
or 2.5 mMofMitoSOX for 20min andwashed three timeswith PBS. TMRMfluo-
rescence was measured with a SpectraMaX M2 microplate reader (Molecular
Devices Corp., Sunnyvale, CA) or by fluorescence microscopy (Nikon Eclipse412 Immunity 36, 401–414, March 23, 2012 ª2012 Elsevier Inc.T2000). MitoSOX fluorescence was measured by an epifluorescence micro-
scope (Olympus IX70; 203 Objective, Texas Red filter cube). Time-lapse
images of live-cell fluorescence with and without ATP stimulus were obtained
by CellSens software and quantitative analysis was performed with ImageJ
software. Care was taken to optimize the fluorescence excitation conditions
so as to minimize photobleaching of the fluoropores during data acquisition.
Immunoblot
BMDM were stimulated for various times, supernatants were collected,
proteins were precipitated bymethanol-chloroform extraction, and cell lysates
were collected. Immunoblot analysis was done with various primary anti-
bodies: anti-mouse caspase-1 p10 (sc-514; Santa Cruz Biotechnology),
anti-mouse IL-1b (AF-401-NA; R&D Systems), or anti-GAPDH (6C5; Santa
Cruz Biotechnology).
Immunoprecipitation
BMDM were preloaded with BrdU (10 mM) for 48 hr and treated as indicated.
For IPs, the rabbit anti-NLRP3 polyclonal Ab (LifeSpan BioSciences Inc.,
Seattle, WA) was incubated with the cell lysates for 2 hr or overnight at 4C.
Subsequently, Trueblot IgG beads (eBioscience, San Diego, CA) were added
and the samples were incubated at 4C for 1 hr. For IPs from Flag-NLRP3
stably expressing 293 cells, mouse anti-Flag mAb (M2, Sigma) was used.
The immune complexes were then washed, the associated proteins were
eluted from the beads by boiling, and then the supernatant was dot-blotted
and UV cross-linked to a nitrocellulose membrane. Immunoblotting was per-
formed with BrdU mAb (BU33; Sigma) or mouse anti-8OH-dG mAb (15A3;
Rockland Immunochemicals Inc., Gilbertsville, PA).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two movies and can be found with this article online at
doi:10.1016/j.immuni.2012.01.009.
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